Alx Oncology Holdings (ALXO) Current Leases (2021 - 2023)

Alx Oncology Holdings has reported Current Leases for 3 years, with the latest figure at $777000.0 in Q1 2023.

• Quarterly Current Leases rose 30.37% year-over-year to $777000.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $777000.0 (up 30.37% YoY) and the FY2022 annual result came in at $755000.0, up 141.21% from the prior year.
• Current Leases advanced to $777000.0 in Q1 2023 per ALXO's latest filing, from $755000.0 in the prior quarter.
• Over five years, Current Leases peaked at $777000.0 in Q1 2023 and troughed at $313000.0 in Q4 2021.
• A 3-year average of $635166.7 and a median of $685000.0 in 2022 frame the typical range for Current Leases.
• The sharpest annual moves came in 2022 and 2023: Current Leases soared 141.21% in 2022, then jumped 30.37% in 2023.
• Over 3 years, Current Leases stood at $313000.0 in 2021, then jumped by 141.21% to $755000.0 in 2022, then gained by 2.91% to $777000.0 in 2023.
• According to Business Quant data, Current Leases over the past three periods registered $777000.0, $755000.0, and $724000.0 for Q1 2023, Q4 2022, and Q3 2022 respectively.